Report Code: A15371 | Pages: NA | Mar 2023 | 684 Views | ||
Author(s) : NA | Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Duane Syndrome Treatment Market
Request Now !Duane syndrome, also known as Duane retraction syndrome (DRS), is a non-progressive congenital strabismus caused by faulty development of the 6th cranial nerve. It is distinguished by difficulty in rotating one or both eyes outward (abduction) or inward (adduction). In Duane syndrome, the 6th cranial nerve, which controls the lateral rectus muscle (the muscle that moves the eye out towards the ear), does not grow properly. It is unclear why the nerve does not grow. As a result, the problem is not with the eye muscle but with the nerve that regulates it. Miswiring of the 3rd cranial nerve, which normally controls the medial rectus muscle (the muscle that rotates the eye toward the nose), can also be related to the Duane syndrome. As a result, anomalies might be seen in both left and right gaze.
Duane syndrome is frequently distinguished by whether the predominant defect is a reduced ability to turn the affected eye(s) outward (type I), inward (type II), or both (type III). Type I Duane syndrome is the most prevalent type, and affected patients have a head turn to the implicated side and seem esotropic (crossed-eyed) in straight-ahead gaze.
COVID-19 Impact Analysi
Pharmaceutical and biotech companies together with governments globally are working to address the COVID-19 issue, right from supporting the development of vaccines to planning for medicine supply chain challenges.
Currently, about 115 vaccine samples and 155 molecules are in the R&D pipeline. Moreover, the implementation of lockdown due to the COVID-19 pandemic has delayed treatment for Duane syndrome; thereby, having a negative impact on the market. This was attributed to the fact that due to the COVID-19 pandemic, many hospitals across the globe were restructured to increase hospital capacity for patients diagnosed with COVID-19. This has led to cancellation of many non-essential services. Moreover, the quality of care toward patients other than COVID-19 has also decreased.
Top Impacting Factors
Market Trends
New Product Launches to Flourish Duane Syndrome Treatment Market
In January 2020, Quest Diagnostics acquired Blueprint Genetics to enhance its expertise in genetic disorders and rare diseases.Â
In June 2018, Centogene launched its diagnostic laboratory in Cambridge, Massachusetts.
In February 2020, Dante Labs launched an initiative to offer WGS to patients with rare diseases for $299. The service included WGS 30X on Novaseq6000 technology, data interpretation, and personalized therapy on these diseases.
Key Benefits of Report
Questions Answered in Duane Syndrome Treatment Market Report
Duane Syndrome Treatment Market Report Highlights
Aspects | Details |
---|---|
By Type |
|
By Treatment |
|
By Diagnosis |
|
By End User |
|
By Region |
|
Key Market Players | Quest Diagnostics, Inc., Centogene N.V., Invitae Corp., 3billion, Inc., ARUP Laboratories, Eurofins Scientific, Strand Life Sciences, Ambry Genetics, Perkin Elmer, Inc., Macrogen, Inc., Baylor Genetics, Color Genomics, Inc., Health Network Laboratories, Preventiongenetics, Progenity, Inc., Coopersurgical, Inc., Fulgent Genetics Inc., Myriad Genetics, Inc., Laboratory Corporation of America Holdings, Opko Health, Inc. |
Loading Table Of Content...
Start reading.
This Report and over 19,609+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers